Dabigatran bleed risk with closed head injuries: Are we prepared?

Journal of Neurosurgery

Volumn 119, Issue 3, 2013, Pages 760-765

  Parra, Michael W ^a,b   Zucker, Lloyd ^a   Johnson, Eric S ^a,b   Gullett, Diane ^a   Avila, Cristina ^a,b   Wichner, Zachary A ^a,b   Kokaram, Candace R ^a  

^a Delray Beach   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Anticoagulation reversal protocol; Closed head injury; Dabigatran; Traumatic brain injury; Warfarin

Indexed keywords

DABIGATRAN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLOSED HEAD INJURY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; FEMALE; HEAD INJURY; HUMAN; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

ACCIDENTAL FALLS; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; CEREBRAL HEMORRHAGE, TRAUMATIC; CLINICAL PROTOCOLS; CRANIOCEREBRAL TRAUMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WARFARIN; YOUNG ADULT;

EID: 84882267105     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.3.JNS12503     Document Type: Article

References (21)

1. American College of Surgeons: National Trauma Databank Report 2006, Version 6.0. (http://www.facs.org/trauma/ntdb/pdf/ntdbannualreport2006.pdf) [Accessed March 5, 2013]
2. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151, 2009
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375, 2001 (Pubitemid 32424106)
4. Hanley JP: Warfarin reversal. J Clin Pathol 57:1132-1139, 2004 (Pubitemid 39486516)
5. Howard JL II, Cipolle MD, Horvat SA, Sabella VM, Reed JF III, Fulda G, et al: Preinjury warfarin worsens outcome in elderly patients who fall from standing. J Trauma 66:1518-1524, 2009
6. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ: Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma 59:1131-1139, 2005 (Pubitemid 43060969)
7. Kalina M, Tinkoff G, Gbadebo A, Veneri P, Fulda G: A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy. Am Surg 74:858-861, 2008
8. Makris M, Watson HG: The management of coumarin-induced over-anticoagulation annotation. Br J Haematol 114: 271-280, 2001
9. Osler T, Hales K, Baack B, Bear K, Hsi K, Pathak D, et al: Trauma in the elderly. Am J Surg 156:537-543, 1988 (Pubitemid 19017545)
10. Perdue PW, Watts DD, Kaufmann CR, Trask AL: Differences in mortality between elderly and younger adult trauma patients: geriatric status increases risk of delayed death. J Trauma 45:805-810, 1998 (Pubitemid 28480587)
11. Safaoui MN, Aazami R, Hotz H, Wilson MT, Margulies DR: A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage. Am J Surg 197:785-790, 2009
12. Sartori MT, Imbergamo S, Zanon E, Bonaccorso G, Pittoni G, Feltracco P, et al: Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center. Clin Appl Thromb Hemost 15:628-635, 2009
13. Sørensen B, Ingerslev J: A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic Response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate. Thromb Haemost 96:446-453, 2006 (Pubitemid 44560678)
14. Stangier J: Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 47:285-295, 2008 (Pubitemid 351508116)
15. Stangier J, Rathgen K, Stähle H, Mazur D: Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet 49:259-268, 2010
16. Susman M, DiRusso SM, Sullivan T, Risucci D, Nealon P, Cuff S, et al: Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma 53:219-224, 2002
17. Testerman GM, Shilad S, George KJ: Rapid warfarin reversal with factor VIIa in an elderly trauma patient with retroperitoneal hematoma. Tenn Med 102:37-39, 2009
18. Tran A, Cheng-Lai A: Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin. Cardiol Rev 19:154-161, 2011
19. van Ryn J, Ruehl D, Priepke H, Hauel N, Wienen W: Reversibility of the anticoagulant effect of high doses of the direct thrombin inhibitor dabigatran, by recombinant Factor VIIa or activated prothrombin complex concentrate. Haematologica 93 (Suppl 1):148, 2008 (Abstract)
20. van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, et al: Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103:1116-1127, 2010
21. Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, et al: Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 376:975-983, 2010